Clinion Achieves GDPR Compliance – Strengthening Patient Data Security

Clinion is proud to announce that its AI-enabled eClinical platform, ClinionAI, is now fully compliant with the General Data Protection Regulation (GDPR). GDPR sets strict requirements for protecting personal data from unauthorized access, disclosure, alteration, or destruction, and ensures that organizations collecting digital data adhere to the highest standards of privacy and security.

Clinion is among the few eClinical platforms to achieve GDPR compliance, reinforcing its commitment to safeguarding patient data. This paves the way for-

• ensuring that data is encrypted and stored securely
• making sure that only authorised personnel have access to data
• responding promptly to client and patient requests

Our integrated eClinical platform supports leading pharmaceutical companies, CROs, and academic research organizations worldwide in conducting clinical trials efficiently and securely. Achieving GDPR compliance underscores Clinion’s dedication to providing a safe, reliable, and compliant environment for clinical research while maintaining the highest standards of data protection.